Status:
WITHDRAWN
Fecal Microbiota Transplantation for Eradication of Carbapenem-resistant Enterobacteriaceae Colonization
Lead Sponsor:
Rambam Health Care Campus
Conditions:
Antibiotic Resistant Strain
Microbial Colonization
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Antibiotic resistance has emerged world wide and is of major concern. Multidrug resistant (MDR) bacteria is widely spread and is now a major factor in morbidity and mortality in health-care settings. ...
Detailed Description
Antibiotic resistance has emerged world wide and is of major concern. Multidrug resistant (MDR) bacteria is widely spread and is now a major factor in morbidity and mortality in health-care settings. ...
Eligibility Criteria
Inclusion
- Adult inpatients ≥18 years positive for CRE of any strain and resistance mechanism in rectal surveillance stool samples, with or without CRE clinical samples. Positive rectal swab within one week before randomization will be mandatory.
Exclusion
- Pregnant women
- Patients with severe neutropenia (\<100/μl)
- Major abdominal surgery
Key Trial Info
Start Date :
January 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2020
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03391674
Start Date
January 1 2019
End Date
January 1 2020
Last Update
January 22 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rambam Health Care Campus
Haifa, Israel